Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2189-2196

  McCollister, Bruce D ^a,b   Hoffman, Matthew ^a   Husain, Maroof ^a   Vázquez Torres, Andrés ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYSTREPTAMINE; AEROBIC RESPIRATION CONTROL PROTEIN A; AMINOGLYCOSIDE; CYTOCHROME C OXIDASE; GAMMA INTERFERON; GENTAMICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; QUINOLINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; BACTERIAL MEMBRANE; CYTOTOXICITY; DRUG UPTAKE; ELECTRON TRANSPORT; MACROPHAGE; NITROSYLATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FUNCTION; SALMONELLA; STAPHYLOCOCCUS AUREUS; STATIC ELECTRICITY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; NITRIC OXIDE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 79955527630     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01203-10     Document Type: Article

References (50)

1. Aires, J. R., T. Kohler, H. Nikaido, and P. Plesiat. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
2. Barcia-Macay, M., C. Seral, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50:841-851.
3. Bates, D. M., et al. 2003. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J. Infect. Dis. 187:1654-1661.
4. Bryan, L. E., and S. Kwan. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23:835-845.
5. Bryan, L. E., and H. M. Van den Elzen. 1976. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 9:928-938.
6. Butler, C. S., H. E. Seward, C. Greenwood, and A. J. Thomson. 1997. Fast cytochrome bo from Escherichia coli binds two molecules of nitric oxide at CuB. Biochemistry 36:16259-16266.
7. r cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.
8. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
9. Drevets, D. A., B. P. Canono, P. J. Leenen, and P. A. Campbell. 1994. Gentamicin kills intracellular Listeria monocytogenes. Infect. Immun. 62: 2222-2228.
10. Ellermeier, C. D., A. Janakiraman, and J. M. Slauch. 2002. Construction of targeted single copy lac fusions using lambda Red and FLP-mediated site-specific recombination in bacteria. Gene 290:153-161.
11. Finken, M., P. Kirschner, A. Meier, A. Wrede, and E. C. Bottger. 1993. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S rRNA pseudoknot. Mol. Microbiol. 9:1239-1246.
12. Fritsche, T. R., M. Castanheira, G. H. Miller, R. N. Jones, and E. S. Armstrong. 2008. Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob. Agents Chemother. 52:1843-1845. (Pubitemid 351614683)
13. Gosselin, D., et al. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
14. Gusarov, I., K. Shatalin, M. Starodubtseva, and E. Nudler. 2009. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380-1384.
15. Hamrick, T. S., A. H. Diaz, E. A. Havell, J. R. Horton, and P. E. Orndorff. 2003. Influence of extracellular bactericidal agents on bacteria within macrophages. Infect. Immun. 71:1016-1019.
16. Hocquet, D., et al. 2003. MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47:1371-1375.
17. Hori, H., M. Tsubaki, T. Mogi, and Y. Anraku. 1996. EPR study of NO complex of bd-type ubiquinol oxidase from Escherichia coli. J. Biol. Chem. 271:9254-9258.
18. Husain, M., et al. 2008. Nitric oxide evokes an adaptive response to oxidative stress by arresting respiration. J. Biol. Chem. 283:7682-7689.
19. Ilag, L. L., D. Jahn, G. Eggertsson, and D. Soll. 1991. The Escherichia coli hemL gene encodes glutamate 1-semialdehyde aminotransferase. J. Bacteriol. 173:3408-3413.
20. MacMicking, J. D., et al. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 94:5243-5248.
21. Magnet, S., and J. S. Blanchard. 2005. Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105:477-498.
22. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation- cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.
23. Mahoney, E., et al. 2002. Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds. Am. J. Pathol. 161:2143-2152.
24. Major, T. A., et al. 2010. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother. 54:4671-4677.
25. Mason, M. G., et al. 2009. Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nat. Chem. Biol. 5:94-96.
26. Mastroeni, P., et al. 2000. Antimicrobial actions of the NADPH Phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192:237-247.
27. McCollister, B. D., et al. 2008. N2O3 enhances the nitrosative potential of IFNγ-primed macrophages in response to Salmonella. Immunobiology 212: 759-769. (Pubitemid 350246256)
28. Menashe, O., E. Kaganskaya, T. Baasov, and S. Yaron. 2008. Aminoglycosides affect intracellular Salmonella enterica serovars Typhimurium and Virchow. Antimicrob. Agents Chemother. 52:920-926.
29. Miller, M. H., S. C. Edberg, L. J. Mandel, C. F. Behar, and N. H. Steigbigel. 1980. Gentamicin uptake in wild-type and aminoglycoside-resistant smallcolony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18:722-729.
30. Nathan, C., and Q. W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
31. Pollock, J. D., et al. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
32. Poteete, A. R., and A. C. Fenton. 1984. Lambda Red-dependent growth and recombination of phage P22. Virology 134:161-167.
33. Prammananan, T., et al. 1998. A single 16S rRNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177: 1573-1581.
34. Proctor, R. A., P. van Langevelde, M. Kristjansson, J. N. Maslow, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102.
35. Proctor, R. A., et al. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295-305.
36. Radi, R., A. Cassina, and R. Hodara. 2002. Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 383:401-409.
37. Richardson, A. R., P. M. Dunman, and F. C. Fang. 2006. The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol. Microbiol. 61:927-939.
38. Rosenberg, E. Y., D. Ma, and H. Nikaido. 2000. AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182:1754-1756. (Pubitemid 30121142)
39. Sasaki, S., et al. 1998. Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect. Immun. 66:1017-1022.
40. Shiloh, M. U., et al. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10: 29-38.
41. Stevanin, T. M., et al. 2000. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J. Biol. Chem. 275:35868-35875.
42. Stuehr, D. J. 1999. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 1411:217-230.
43. Taber, H. W., J. P. Mueller, P. F. Miller, and A. S. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439-457.
44. Vakulenko, S. B., and S. Mobashery. 2003. Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16:430-450.
45. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulous, and F. C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227-236.
46. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
47. von Eiff, C., et al. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.
48. Wachino, J., et al. 2007. Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob. Agents Chemother. 51:4401-4409.
49. Yoon, S. S., et al. 2006. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116:436-446.
50. Yu, H., et al. 1997. Oxygen-dependent regulation of the respiration and growth of Escherichia coli by nitric oxide. FEBS Lett. 409:161-165. (Pubitemid 27273869)